Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 1
2014 4
2015 5
2016 4
2017 6
2018 3
2019 5
2020 4
2021 6
2022 10
2023 9
2024 5
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
International Psoriasis Council psoriasis disease severity reclassification: Update on validity, acceptance, and implementation.
Strober BE, Blauvelt A, van de Kerkhof PC, González-Cantero Á, El-Kalioby M, Gonzalez C, Matlock BH, Rob F, Asawanonda P, Chandra R, Maul JT, Torres T, Skov L. Strober BE, et al. Among authors: rob f. J Am Acad Dermatol. 2025 Oct;93(4):1154-1157. doi: 10.1016/j.jaad.2025.05.1445. Epub 2025 Jun 6. J Am Acad Dermatol. 2025. PMID: 40484137 Free article. No abstract available.
Establishing consensus on defining failure of topical therapy in psoriasis: Recommendations from the International Psoriasis Council.
Strober BE, Blauvelt A, van de Kerkhof PCM, Asawanonda P, Chandra R, Gonzalez-Cantero A, Gonzalez C, Matlock BH, Maul JT, Rob F, Torres T, Skov L. Strober BE, et al. Among authors: rob f. J Am Acad Dermatol. 2025 Sep 11:S0190-9622(25)02802-6. doi: 10.1016/j.jaad.2025.08.116. Online ahead of print. J Am Acad Dermatol. 2025. PMID: 40945737 Free article. No abstract available.
Efficacy and safety of lebrikizumab in atopic dermatitis over 24 weeks: An analysis from the BIOREP registry.
Rob F, Gkalpakiotis S, Kojanová M, Vantuchová Y, Čelakovská J, Horažďovský J, Baláž M, Nečas M, Stuchlík D, Cetkovská P, Hrazdírová K, Machovcová A, Pinková B, Třešňák Hercogová J. Rob F, et al. J Eur Acad Dermatol Venereol. 2025 Aug 13. doi: 10.1111/jdv.70009. Online ahead of print. J Eur Acad Dermatol Venereol. 2025. PMID: 40799158 No abstract available.
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy.
Reiss Z, Rob F, Kolar M, Schierova D, Kreisinger J, Jackova Z, Roubalova R, Coufal S, Mihula M, Thon T, Bajer L, Novakova M, Vasatko M, Kostovcikova K, Galanova N, Lukas M, Kverka M, Tresnak Hercogova J, Tlaskalova-Hogenova H, Jiraskova Zakostelska Z. Reiss Z, et al. Among authors: rob f. Front Cell Infect Microbiol. 2023 Jan 10;12:1064537. doi: 10.3389/fcimb.2022.1064537. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36704107 Free PMC article.
62 results